Dipyridamole (Roxane Laboratories, Inc.)


Welcome to the PulseAid listing for the Dipyridamole drug offered from Roxane Laboratories, Inc.. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Roxane Laboratories, Inc.
NON-PROPRIETARY NAME: Dipyridamole
SUBSTANCE NAME: DIPYRIDAMOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2012-02-15
END MARKETING DATE: 0000-00-00


Dipyridamole HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDipyridamole from Roxane Laboratories, Inc.
LABELER NAME: Roxane Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mg/1)
START MARKETING DATE: 2012-02-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0054-0434_ae7585ec-1280-40fe-b888-613b8a0e6ef6
PRODUCT NDC: 0054-0434
APPLICATION NUMBER: NDA012836

Other DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationDipyridamole
Avera McKennan HospitalDipyridamole
Boehringer Ingelheim Pharmaceuticals, Inc.Persantine
Cadila Healthcare LimitedDipyridamole
Cardinal HealthDIPYRIDAMOLE
Carilion Materials ManagementDipyridamole
General Injectables & Vaccines, IncDipyridamole
Lannett Company, Inc.Dipyridamole
Major PharmaceuticalsDIPYRIDAMOLE
NCS HealthCare of KY, Inc dba Vangard LabsDipyridamole
Rising Pharmaceuticals, Inc.DIPYRIDAMOLE
Roxane Laboratories, Inc.Dipyridamole
Teva Pharmaceuticals USA, Inc.Dipyridamole
West-ward Pharmaceutical Corp.Dipyridamole
Zydus Pharmaceuticals (USA) Inc.Dipyridamole